Jci_page_head_homepage_01 Jci_page_head_homepage_02
Michael J. Taggart, G. Nicholas Europe-Finner, Bryan F. Mitchell
Published in Volume 118, Issue 12
J Clin Invest. 2008; 118(12):3829–3832 doi:10.1172/JCI37785
Abstract | Full text | PDF
Options: View larger image (or click on image)
Medium
Figure 1
Possible pathways of prostacyclin-mediated stimulation of cAMP and myometrial activation.

Receptor-coupled Gαs stimulation of myometrial adenylyl cyclase (AC) activity raises intracellular cAMP levels. Prostacyclin, or hIP agonist iloprost, act via this route. cAMP is traditionally thought to set in operation a cascade involving activation of PKA bound to anchoring proteins (e.g., AKAP79), release of PKA catalytic subunits (C) from regulatory RIIβ subunits (R), and subsequent phosphorylation of intracellular proteins that effect myometrial relaxation and quiescence. An additional longer-term effect of Gαs-dependent cAMP elevation is promotion of the expression of genes encoding proteins with relaxant influences. Normally, Gαs stimulation of cAMP levels would alter gene expression via nuclear PKA (possibly bound to AKAP95) stimulation and subsequent activation of cAMP-dependent transcription factors, such as CREB and CREM. The report by Fetalvero et al. in this issue of the JCI (4) challenges the latter theory by suggesting that the Gαs-coupled receptor hIP actually induces, by raising cAMP levels, the positive transcription of genes encoding several proteins that are more associated with uterine activation prior to labor: SM2-MHC, h-caldesmon, α-SMA, calponin, and connexin 43 (Cx43). It remains to be determined whether hIP alteration of myometrial expression of these genes occurs via the cAMP-dependent transcription factors CREB and CREM. An alternative possibility may be for hIP (and other stimuli that raise cAMP levels) to activate another class of cAMP-responsive transducing molecules known as exchange proteins directly activated by cAMP (EPACs). Their role in human myometrium, and myometrial prostacyclin-dependent signaling pathways, remains to be resolved.